Mark Penney
Impact in
- Neurology top 10%
- Neurological diseases and metabolism
- Internal Medicine top 10%
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 2
- Co-authors
- David A. Hilton (4 shared papers)P. G. Edwards (2 shared papers)Linda McCardle (2 shared papers)Diane Ritchie (2 shared papers)James W. Ironside (2 shared papers)Doha Hegazy (1 shared paper)Azra C. Ghani (1 shared paper)Paul Newbold (3 shared papers)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (6 papers)Gastroenterology (2 papers)British Journal of Clinical Pharmacology (1 paper)Histopathology (1 paper)Journal of Clinical Pathology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Mark Penney
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Neurology 110
- Internal Medicine 38
- Immunology 193
- Molecular Biology 531
- Genetics 73
Countries citing papers authored by Mark Penney
This map shows the geographic impact of Mark Penney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Penney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Penney more than expected).
Fields of papers citing papers by Mark Penney
This network shows the impact of papers produced by Mark Penney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Penney. The network helps show where Mark Penney may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Penney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 325 | |
| 2 | 2017 | 226 | |
| 3 | 2017 | 79 | |
| 4 | 2002 | 76 | |
| 5 | 2018 | 67 | |
| 6 | 2015 | 66 | |
| 7 | 2019 | 64 | |
| 8 | 2004 | 59 | |
| 9 | 2019 | 45 | |
| 10 | 2004 | 33 | |
| 11 | 2002 | 24 | |
| 12 | 2020 | 24 | |
| 13 | 2015 | 19 | |
| 14 | 2014 | 18 | |
| 15 | 2021 | 14 | |
| 16 | 2013 | 9 | |
| 17 | 2016 | 8 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 0 |
About Mark Penney
Mark Penney is a scholar working on Molecular Biology, Immunology, Oncology, Genetics and Computational Theory and Mathematics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glioma Diagnosis and Treatment (3 papers), Cancer-related Molecular Pathways (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Platelet Disorders and Treatments (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Neurology (110 citations), Internal Medicine (38 citations), Immunology (193 citations), Molecular Biology (531 citations) and Genetics (73 citations). Mark Penney has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include David A. Hilton, P. G. Edwards, Linda McCardle, Diane Ritchie, James W. Ironside, Doha Hegazy, Azra C. Ghani, Paul Newbold, René van der Merwe and Andrew Demaine. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Gastroenterology, British Journal of Clinical Pharmacology, Histopathology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.